News

The Latest News from LGM Pharma

LGM Pharma Unveils Enhanced Analytical Testing Services and Expands CDMO Portfolio with Additional Suppository Manufacturing Capabilities
—50% expansion and over $2 million investment in standalone analytical testing services (ATS); offers...
LGM PHARMA REPORTS STRONG REVENUES IN FIRST YEAR OF CDMO OPERATIONS ALONG WITH CONTINUED GROWTH IN ITS API SOURCING BUSINESS
─CDMO Clinical and Commercial Manufacturing Services, Including Analytical Testing and Drug Product R&D...
LGM pharma’s unique mix of API sourcing and CDMO services is fueling robust growth
─Customer Projects Bridging LGM Pharma’s API Sourcing and CDMO Services Range from Promising Pharmaceutical...
LGM Pharma launches standalone analytical services for drug developers and manufacturers
─Analytical Testing and Stability Services Covering Both Drug Substance and Drug Product are Available...
NAI/Merin Hunter Codman negotiates 33,488 sf lease on behalf of Boca Raton’s LGM Pharma as part of their Nexgen Pharma acquisition
Boca Raton, FL & Irvine, CA RELEASE PDF– NAI/Merin Hunter Codman, a leading South Florida commercial...
LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma
LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable...
1 2